Gossamer Bio Inc. (GOSS)

1.18

-0.05 (-4.07%)

At close: Mar 03, 2025, 11:23 AM

Gossamer Bio Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-179.82M	-229.38M	-234M	-243.36M	-180.31M	-146.97M	-6.77M	-83K
Depreciation & Amortization	4.38M	4.43M	5.17M	4.27M	3.09M	297K	n/a	n/a
Stock-Based Compensation	28.52M	42.55M	32.01M	38.75M	20.82M	30.95M	32K	n/a
Other Working Capital	-18.83M	-2.65M	5.2M	-10.08M	11.52M	12.94M	937K	103K
Other Non-Cash Items	2.6M	-177K	6.81M	27.24M	3.84M	49.66M	32K	103K
Deferred Income Tax	n/a	n/a	359K	-158K	-2.39M	n/a	n/a	n/a
Change in Working Capital	-14.84M	-4.46M	774K	-3.1M	10.12M	15.02M	994K	103K
Operating Cash Flow	-159.16M	-187.03M	-188.89M	-176.36M	-144.83M	-51.04M	-5.75M	20K
Capital Expenditures	n/a	-475K	-1.62M	-24.88M	-6.57M	-21.21M	n/a	n/a
Acquisitions	n/a	-65K	75K	23.38M	3.6M	-17.72M	n/a	n/a
Purchase of Investments	-441.67M	-238.06M	-152.03M	-108.97M	-499.08M	-123.5M	n/a	n/a
Sales Maturities Of Investments	330.7M	237.5M	36.23M	349.19M	358.5M	n/a	n/a	n/a
Other Investing Acitivies	n/a	65K	-75K	-23.38M	-3.6M	17.72M	n/a	n/a
Investing Cash Flow	-110.97M	-1.03M	-117.43M	215.34M	-147.14M	-144.71M	n/a	n/a
Debt Repayment	-11.61M	-5.81M	n/a	193.6M	28.22M	-40K	6M	40K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	888K	2.95M	3.33M	1.83M	293.36M	300.9M	n/a	n/a
Financial Cash Flow	190.15M	117.09M	3.33M	312.54M	321.58M	300.86M	6M	40K
Net Cash Flow	-79.86M	-71.49M	-303.15M	351.53M	29.67M	105.1M	255K	n/a
Free Cash Flow	-159.16M	-187.51M	-190.51M	-201.24M	-151.4M	-72.25M	-5.75M	20K